专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明授权

US06975271B2 Antenna switch module, all-in-one communication module, communication apparatus and method for manufacturing antenna switch module 失效
标题翻译：天线开关模块，一体化通信模块，通信装置及制造天线开关模块的方法
公开(公告)号：US06975271B2
公开(公告)日：2005-12-13
申请号：US10786434
申请日：2004-02-25
申请人： Masakazu Adachi , Kazuhide Uriu , Toshio Ishizaki
发明人： Masakazu Adachi , Kazuhide Uriu , Toshio Ishizaki
IPC分类号： H04B1/44 , H01P1/15 , H01Q1/26
CPC分类号： H01P1/15
摘要： To realize high pressure-tightness and improvement in a high-frequency characteristic due to a low impedance between a shunt FET and a ground of a FET switch circuit. An antenna switch module comprising a switch circuit for switching between transmitting and receiving of a signal between an antenna and a transmitting portion and/or a receiving portion and having a shunt circuit, wherein a capacitor of the shunt circuit of the switch circuit is provided to a dielectric layered body, and remaining elements of the switch circuit are provided to semiconductor chips mounted on the dielectric layered body.
摘要翻译：由于分流FET与FET开关电路的接地之间的低阻抗，实现了高压特性的高压紧性和改善。一种天线开关模块，包括用于在天线与发射部分和/或接收部分之间的信号的发送和接收之间切换并具有分流电路的开关电路，其中开关电路的分流电路的电容器被提供到电介质层叠体和开关电路的剩余元件设置在安装在电介质层叠体上的半导体芯片上。

32. 发明授权

US5725768A Granulocyte removing apparatus 失效
标题翻译：粒细胞去除装置
公开(公告)号：US5725768A
公开(公告)日：1998-03-10
申请号：US353277
申请日：1994-12-05
申请人： Masakazu Adachi , Masahiro Nakatani , Seiichirou Honda
发明人： Masakazu Adachi , Masahiro Nakatani , Seiichirou Honda
IPC分类号： G01N33/50 , A61K35/14 , A61M1/36 , B01D24/00 , B01D39/04
CPC分类号： A61M1/3679 , A61M2202/0413 , A61M2202/0415 , A61M2202/0427 , A61M2202/0433 , A61M2202/0439 , A61M2202/0441
摘要： Granulocytes can be removed from blood by bringing the blood into contact with a carrier having higher affinity to granulocytes than to lymphocytes. the carrier may preferably be a substance having a contact angle in a range of 55.degree.-95.degree. to water, e.g., polystyrene, cellulose acetate, nylon, polytrifluoroethylene or polyethylene terephthalate. A granulocyte removing apparatus is also disclosed. It comprises a granulocyte-adsorbing portion enclosing therein a carrier having higher affinity to granulocytes than to lymphocytes, a blood inflow port for causing blood to flow into the adsorbing portion, and a blood outflow port for allowing the blood, which has flowed in the adsorbing portion, to flow out of the adsorbing portion.
摘要翻译：可以通过使血液与对粒细胞具有更高亲和力的载体与淋巴细胞接触来从血液中除去粒细胞。载体可优选为与水例如聚苯乙烯，乙酸纤维素，尼龙，聚三氟乙烯或聚对苯二甲酸乙二醇酯接触角在55-95℃范围内的物质。还公开了一种粒细胞去除装置。它包括粒细胞吸附部分，其中包含对淋巴细胞具有对粒细胞的亲和力高的载体，用于使血液流入吸附部分的血液流入口，以及用于允许流入吸附的血液的血液流出口从吸附部流出。

33. 发明授权

US5403719A Method for assessing prognosis of a patient undergoing therapy for cancer 失效
标题翻译：评估接受癌症治疗的患者预后的方法
公开(公告)号：US5403719A
公开(公告)日：1995-04-04
申请号：US257572
申请日：1994-06-09
申请人： Masakazu Adachi , Masahiro Nakatani , Seiichirou Honda
发明人： Masakazu Adachi , Masahiro Nakatani , Seiichirou Honda
IPC分类号： G01N33/50 , A61K35/14 , A61M1/36 , C12Q1/02 , A61M35/00 , C12N1/00 , G01N33/48
CPC分类号： A61M1/3679 , A61M2202/0413 , A61M2202/0415 , A61M2202/0427 , A61M2202/0433 , A61M2202/0439 , A61M2202/0441
摘要： A method for assessing the prognosis of a patient undergoing therapy for cancer by measuring the granulocyte/lymphocyte ratio of the patient's blood and comparing the ratio to a normal range of 1.6.+-.0.6. The prognosis is considered improved when the G/L value is within the range as compared to when it is greater than the same.
摘要翻译：通过测量患者血液的粒细胞/淋巴细胞比例并将比率与1.6 +/- 0.6的正常范围进行比较来评估接受癌症治疗的患者的预后的方法。当G / L值在大于相同值的范围内时，预后被认为是改善的。

34. 发明授权

US5190916A Use of ovomacroglobulin as an agent for treating wound and inflammation 失效
标题翻译：使用奥美洛林作为治疗发作和炎症的药剂
公开(公告)号：US5190916A
公开(公告)日：1993-03-02
申请号：US157508
申请日：1988-02-08
申请人： Masakazu Adachi
发明人： Masakazu Adachi
IPC分类号： A61K8/64 , A61K38/00 , A61Q7/00 , C07K14/81
CPC分类号： C07K14/8107 , A61K8/64 , A61Q7/00 , A61K38/00 , Y10S514/88 , Y10S514/884 , Y10S514/886 , Y10S514/887
摘要： A treating agent such as a wound therapeutic agent, inflammation therapeutic agent, hair growth agent and hair tonic, and a cosmetic, comprising as an effective component ovomacroglobulin are disclosed. They can act on the skin, a scalp or hairs to exhibit excellent wound curing promotion effect, hair growth promotion effect, and skin or hair protective effect.

35. 发明授权

US5183738A Kit for the detection of denatured lipoproteins 失效
标题翻译：用于检测变性脂蛋白的试剂盒
公开(公告)号：US5183738A
公开(公告)日：1993-02-02
申请号：US413484
申请日：1989-09-27
申请人： Masakazu Adachi , Toshimitu Saitou , Kimiyo Murata , Aki Tamura
发明人： Masakazu Adachi , Toshimitu Saitou , Kimiyo Murata , Aki Tamura
IPC分类号： G01N33/92
CPC分类号： G01N33/92 , G01N2800/044 , Y10S435/962 , Y10S436/825
摘要： A kit and a method for detecting denatured lipoproteins is disclosed. The method comprises: adding to a sample a mixture of (i) an affinity gel with which a monoclonal antibody for apoprotein A-I is coupled and (ii) an affinity gel with which a monoclonal antibody for apoprotein B-100 is coupled; removing apoprotein A-I and apoprotein B-100 in the sample by combining the apoprotein A-I and apoprotein B-100 with the affinity gels; and measuring an amount of lipoproteins in the residue. The kit comprises a mixture of (i) and (ii) as an essential component. The kit and the method is useful for the clinical investigation and diagnosis of abnormal lipid metabolism which can be a cause of heart diseases (e.g. cardiac infarction), diabetes, and various types of atherosclerosis diseases.
摘要翻译：公开了一种用于检测变性脂蛋白的试剂盒和方法。该方法包括：向样品中加入以下混合物：（i）与载体蛋白A-1的单克隆抗体偶联的亲和凝胶和（ii）与载脂蛋白B-100偶联的单克隆抗体的亲和凝胶; 通过将载脂蛋白A-1和载脂蛋白B-100与亲和凝胶组合来去除样品中的载脂蛋白A-1和载脂蛋白B-100; 并测量残留物中脂蛋白的量。试剂盒包含（i）和（ii）作为必需组分的混合物。试剂盒和方法对于可能是心脏病（例如心脏梗死），糖尿病和各种类型的动脉粥样硬化疾病的原因的脂质代谢异常的临床研究和诊断是有用的。

36. 发明申请

US20070290744A1 Radio frequency switching circuit, radio frequency switching device, and transmitter module device 审中-公开
标题翻译：射频切换电路，射频切换装置和发射机模块装置
公开(公告)号：US20070290744A1
公开(公告)日：2007-12-20
申请号：US11806303
申请日：2007-05-31
申请人： Masakazu Adachi , Tadayoshi Nakatsuka
发明人： Masakazu Adachi , Tadayoshi Nakatsuka
IPC分类号： H03F1/14
CPC分类号： H03F3/24 , H01L2924/0002 , H03K17/102 , H03K17/693 , H03K2017/6875 , H03K2217/0054 , H01L2924/00
摘要： The present invention provides an inexpensive radio frequency switching circuit having desirable radio frequency characteristics over a wide band and desirable endurance against the inflow of a high voltage signal such as an electrostatic surge. Either a negative bias voltage or a positive bias voltage being greater than or equal to 0V and less than or equal to a Schottky forward voltage is used for the control terminals V11 and V12 for controlling FETs 11 to 18 and FETs 21 to 28 so as to turn ON/OFF the path extending from the first input/output terminal P11 to the second input/output terminal P12 and the path extending from the first input/output terminal P11 to the third input/output terminal P13. Thus, it is possible to eliminate the need for DC cut capacitors.
摘要翻译：本发明提供了一种廉价的射频切换电路，其在宽带上具有期望的射频特性，并且能够抵抗诸如静电浪涌的高电压信号的流入。对于用于控制FET 11至18和FET 21至28的控制端子V 11和V 12，使用大于或等于0V且小于或等于肖特基正向电压的负偏压或正偏压，因此用于将从第一输入/输出端子P11延伸到第二输入/输出端子P12的路径和从第一输入/输出端子P11延伸到第三输入/输出端子P13的路径的ON / OFF。因此，可以消除对直流切断电容器的需要。

37. 发明授权

US06498007B1 Methods of treatment of disease using adsorbent carriers 有权
标题翻译：使用吸附剂处理疾病的方法
公开(公告)号：US06498007B1
公开(公告)日：2002-12-24
申请号：US09700632
申请日：2000-11-17
申请人： Masakazu Adachi , Toshifumi Hibi
发明人： Masakazu Adachi , Toshifumi Hibi
IPC分类号： A61M3700
CPC分类号： C12N5/0087 , A61K35/14 , A61M1/3679 , A61M2202/0439 , A61M2202/206 , Y02A50/411 , A61M2202/0014
摘要： The invention relates to a method for the removal of leucocytes from blood which comprises bringing blood that comprises infected leucocytes into contact with an adsorbent carrier that has a greater affinity for infected, activated and/or defective leucocytes than for uninfected leucocytes especially cellulose acetate. The method can be used in the apheresis treatment of diseases caused by pathogenic organisms, for example, HIV, HCV or malaria. It is especially useful for treatment of HIV.
摘要翻译：本发明涉及一种从血液中去除白细胞的方法，其中包括使含有感染的白细胞的血液与对感染的，活化的和/或有缺陷的白细胞具有比未感染的白细胞，特别是醋酸纤维素更大亲和力的吸附剂载体接触。该方法可用于单因素处理由致病生物体引起的疾病，例如HIV，HCV或疟疾。它特别适用于治疗艾滋病毒。

38. 发明授权

US5872120A Apoptosis regulating composition 失效
标题翻译：凋亡调节组成
公开(公告)号：US5872120A
公开(公告)日：1999-02-16
申请号：US854074
申请日：1997-05-09
申请人： Satoru Nakai , Koutoku Aihara , Hitomi Mori , Michiaki Tominaga , Masakazu Adachi , Hiroyuki Ichikawa , Seiji Akamatsu , Fumio Saito
发明人： Satoru Nakai , Koutoku Aihara , Hitomi Mori , Michiaki Tominaga , Masakazu Adachi , Hiroyuki Ichikawa , Seiji Akamatsu , Fumio Saito
IPC分类号： A61K31/495 , A61K31/496 , A61K31/50
CPC分类号： A61K31/496 , A61K31/495
摘要： An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.
摘要翻译：本发明的目的是提供凋亡调节组合物。根据本发明，提供了一种凋亡调节组合物，其包含至少一种通式（1）的喹诺酮衍生物及其盐作为活性成分。

39. 发明授权

US5798358A Apoptosis regulating composition 失效
公开(公告)号：US5798358A
公开(公告)日：1998-08-25
申请号：US853746
申请日：1997-05-09
申请人： Satoru Nakai , Koutoku Aihara , Hitomi Mori , Michiaki Tominaga , Masakazu Adachi , Hiroyuki Ichikawa , Seiji Akamatsu , Fumio Saito
发明人： Satoru Nakai , Koutoku Aihara , Hitomi Mori , Michiaki Tominaga , Masakazu Adachi , Hiroyuki Ichikawa , Seiji Akamatsu , Fumio Saito
IPC分类号： A61K31/495 , A61K31/496 , A61K31/50
CPC分类号： A61K31/496 , A61K31/495
摘要： An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.

40. 发明授权

US5654343A Method of treating a nitric oxide-associated disease with phenanthrene derivatives 失效
标题翻译：用菲衍生物治疗一氧化氮相关疾病的方法
公开(公告)号：US5654343A
公开(公告)日：1997-08-05
申请号：US495645
申请日：1995-06-06
申请人： Hideki Moritoki , Yoshihisa Takaishi , Masakazu Adachi , Yukihisa Ono
发明人： Hideki Moritoki , Yoshihisa Takaishi , Masakazu Adachi , Yukihisa Ono
IPC分类号： C07C43/215 , C07C45/51 , C07C45/68 , C07C47/575 , C07C49/747 , C07C49/755 , C07C50/34 , C07C50/38 , C07C62/32 , C07C62/34 , C07C62/38 , C07C69/00 , C07C323/65 , C07D207/16 , C07D307/77 , C07F7/18 , C07F9/53 , A61K31/135 , A61K31/03 , A61K31/01
CPC分类号： C07D307/77 , C07C323/65 , C07C43/215 , C07C45/513 , C07C45/68 , C07C47/575 , C07C49/747 , C07C49/755 , C07C50/34 , C07C50/38 , C07C62/32 , C07C62/34 , C07C62/38 , C07D207/16 , C07F7/1856 , C07F9/532 , C07C2103/26 , Y10S514/921
摘要： This invention provides a nitric oxide synthesis inhibitor composition comprising, as an active ingredient, at least one member of the group consisting of various phenanthrene derivatives, typically represented by the following general formula (1), and salts thereof. ##STR1## The nitric oxide synthesis inhibitor composition of this invention is useful for the prophylaxis and therapy of nitric oxide-associated diseases such as endotoxin shock.
摘要翻译： PCT No.PCT / JP94 / 01695 Sec。 371日期：1995年6月6日 102（e）日期1995年6月6日PCT 1994年10月11日PCT PCT。公开号WO95 / 10266 日期1995年04月20日本发明提供一种氧化氮合成抑制剂组合物，其包含作为活性成分的至少一种由通常由以下通式（1）表示的各种菲衍生物及其盐组成的组中的至少一种。（1）本发明的一氧化氮合成抑制剂组合物可用于预防和治疗一氧化氮相关疾病如内毒素休克。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式